Visibility - Classification of Sono-visibility of Anatomical Structures in Peripheral Nerve Blocks (Visibility)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03231696 |
|
Recruitment Status :
Completed
First Posted : July 27, 2017
Last Update Posted : December 15, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease |
|---|
| Anesthesia, Local Anesthesia |
We assessed the visibility of peripheral nerves while ultrasound guided blockades with a novel scoring system to evaluate differences in visibility of different nerves.
VIS(visibility) 1 easy identification and instant visualisation of all structures VIS 2 identification and visualisation of all structures after some corrections VIS 3 identification and visualisation of structures only unsure VIS 4 identification and visualisation of all structures impossible VIS 5 no structures seen. We amended a sub-project in which assessed the visibility in protective nerve stimulated nerve blocks in 46 patients.
| Study Type : | Observational |
| Actual Enrollment : | 1200 participants |
| Observational Model: | Cohort |
| Time Perspective: | Retrospective |
| Official Title: | Visibility - A Novel Classification Score of Sono-visibility of Anatomical Structures in Peripheral Nerve Blocks |
| Actual Study Start Date : | January 2012 |
| Actual Primary Completion Date : | December 2016 |
| Actual Study Completion Date : | December 2016 |
| Group/Cohort |
|---|
|
Patients receiving Regional Anesthesia
All patients 18 years or older with a peripheral nerve block at Charité - Universitätsmedizin Berlin Campus Charite Mitte from 2012 to 2016.
|
- Visibility [ Time Frame: During regional block (an average of 1 hour) ]The ultrasound visibility of the nerve scored by a 5-step scale.
- Additional analgesia [ Time Frame: During surgery (an average of 4 hours) ]The need and amount of additional analgetic drugs while the intervention.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Inclusion Criteria (study sample N=1200):
- peripheral nerve block by ultrasound guidance
- age ≥ 18 years
Exclusion Criteria:
- contraindications for regional anesthesia
Inclusion Criteria (study sample as of amendment n=46):
- peripheral nerve block by ultrasound guidance
- age ≥ 18 years
Exclusion Criteria:
- contraindications for regional anesthesia (study sample n=46)
- using not the standard ultrasound machine
- performing not a standard regional anesthesia
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03231696
| Germany | |
| Department of Anesthesiology and Operative Intensive Care Medicine, CCM and CVK | |
| Berlin, Germany, 10117 | |
| Principal Investigator: | Jürgen Birnbaum, MD | Department of Anesthesiology and Operative Intensive Care Medicine, CCM and CVK |
| Responsible Party: | Jurgen Birnbaum, Senior physician of the Department of Anesthesiology and Operative Intensive Care Medicine, CCM and CVK, Charite University, Berlin, Germany |
| ClinicalTrials.gov Identifier: | NCT03231696 |
| Other Study ID Numbers: |
Visibility |
| First Posted: | July 27, 2017 Key Record Dates |
| Last Update Posted: | December 15, 2017 |
| Last Verified: | December 2017 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
nerve block peripheral nerve stimulation |

